BR0315513A - Composição farmacêutica injetável, processo para preparação de composição farmacêutica, e, uso de cefquinoma em um veìculo com liberação prolongada - Google Patents

Composição farmacêutica injetável, processo para preparação de composição farmacêutica, e, uso de cefquinoma em um veìculo com liberação prolongada

Info

Publication number
BR0315513A
BR0315513A BR0315513-7A BR0315513A BR0315513A BR 0315513 A BR0315513 A BR 0315513A BR 0315513 A BR0315513 A BR 0315513A BR 0315513 A BR0315513 A BR 0315513A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
cefquinome
vehicle
prolonged release
injectable
Prior art date
Application number
BR0315513-7A
Other languages
English (en)
Inventor
Peter Schmid
Alexander Boettner
Carsten Schmidt
Mark Allan
Carole Barbot
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of BR0315513A publication Critical patent/BR0315513A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA INJETáVEL, PROCESSO PARA PREPARAçãO DE COMPOSIçãO FARMACêUTICA, E, USO DE CEFQUINOMA EM UM VEìCULO COM LIBERAçãO PROLONGADA". Composições farmacêuticas de cefquinoma em um veículo com liberação prolongada, que compreende um óleo e diestearato de alumínio, proporcionam uma duração prolongada da concentração efetiva de cefquinoma no sangue-plasma, após a injeção em animais.
BR0315513-7A 2002-10-25 2003-10-20 Composição farmacêutica injetável, processo para preparação de composição farmacêutica, e, uso de cefquinoma em um veìculo com liberação prolongada BR0315513A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02079477 2002-10-25
PCT/EP2003/011644 WO2004037265A1 (en) 2002-10-25 2003-10-20 Prolonged release pharmaceutical composition

Publications (1)

Publication Number Publication Date
BR0315513A true BR0315513A (pt) 2005-08-23

Family

ID=32116298

Family Applications (2)

Application Number Title Priority Date Filing Date
BR0315513-7A BR0315513A (pt) 2002-10-25 2003-10-20 Composição farmacêutica injetável, processo para preparação de composição farmacêutica, e, uso de cefquinoma em um veìculo com liberação prolongada
BRPI0315513-7A BRPI0315513B1 (pt) 2002-10-25 2003-10-20 Pharmaceutical composition preparation, and use of crystalline in a vehicle with prolonged release

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0315513-7A BRPI0315513B1 (pt) 2002-10-25 2003-10-20 Pharmaceutical composition preparation, and use of crystalline in a vehicle with prolonged release

Country Status (18)

Country Link
EP (1) EP1558263B1 (pt)
JP (1) JP4584715B2 (pt)
CN (1) CN1326526C (pt)
AR (1) AR041713A1 (pt)
AT (1) ATE327759T1 (pt)
AU (1) AU2003279302B2 (pt)
BR (2) BR0315513A (pt)
CA (1) CA2501395C (pt)
CO (1) CO5700769A2 (pt)
DE (1) DE60305728T2 (pt)
ES (1) ES2265590T3 (pt)
MX (1) MXPA05004219A (pt)
NO (1) NO334158B1 (pt)
NZ (1) NZ539478A (pt)
PL (1) PL208585B1 (pt)
PT (1) PT1558263E (pt)
WO (1) WO2004037265A1 (pt)
ZA (1) ZA200502956B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007291308A1 (en) * 2006-08-30 2008-03-06 Intervet International B.V. Pharmaceutical compositions comprising cefquinome
AU2007234612B2 (en) 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations
US7678764B2 (en) 2007-06-29 2010-03-16 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations for use at elevated temperatures
US8058237B2 (en) 2007-08-07 2011-11-15 Advanced Technologies & Regenerative Medicine, LLC Stable composition of GDF-5 and method of storage
EP2276458A1 (en) 2008-04-14 2011-01-26 Advanced Technologies and Regenerative Medicine, LLC Liquid buffered gdf-5 formulations
TWI400243B (zh) * 2009-07-20 2013-07-01 Intervet Int Bv 製造西喹諾（ｃｅｆｑｕｉｎｏｍｅ）粒子的方法
WO2012095438A1 (en) * 2011-01-12 2012-07-19 Intervet International B.V. Particles and suspensions of cephalosporin antibiotics
EP2663287A1 (en) * 2011-01-12 2013-11-20 Intervet International B.V. Use of liquid medium exchange by cross flow filtration in the preparation of drug suspensions
CN102319210B (zh) * 2011-09-29 2013-05-01 武汉回盛生物科技有限公司 一种兽用长效硫酸头孢喹肟注射液及其制备方法
CN104546703B (zh) * 2013-12-10 2017-06-23 中国农业科学院饲料研究所 一种奶牛泌乳期用硫酸头孢喹肟乳房注入剂及其制备方法
CN104000783B (zh) * 2014-05-14 2017-12-05 河南牧翔动物药业有限公司 头孢喹肟脂质体
CN104873462B (zh) * 2014-11-18 2017-04-05 中国农业科学院饲料研究所 一种奶牛干乳期用硫酸头孢喹肟乳房注入剂及其制备方法
CN107157927A (zh) * 2017-05-31 2017-09-15 合肥中龙神力动物药业有限公司 动物用硫酸头孢喹肟注射液及其制备方法
CN109044970A (zh) * 2018-11-08 2018-12-21 遂宁市中通实业集团动物药业有限公司 一种硫酸头孢喹肟注射液及其制备方法
CN113209014A (zh) * 2020-01-21 2021-08-06 江西邦诚动物药业有限公司 长效硫酸头孢喹肟混悬注射液及其制备工艺
CN113952298B (zh) * 2021-12-08 2023-02-17 江苏农牧科技职业学院 硫酸头孢喹肟纳米混悬液及其制备方法
CN117982413B (zh) * 2024-04-03 2024-06-18 山东恒邦中科生物工程有限公司 一种硫酸头孢喹肟注射液的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920819A (en) * 1974-12-02 1975-11-18 Lilly Co Eli Nonaqueous vehicle for oral pharmaceutical suspensions
IE49770B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
IE51846B1 (en) * 1980-11-17 1987-04-15 Leo Pharm Prod Ltd Pharmaceutical preparation for veterinary use and an appliance containing it
GB8531609D0 (en) * 1985-12-23 1986-02-05 Beecham Group Plc Compounds
JP3022692B2 (ja) * 1992-10-13 2000-03-21 三菱マテリアル株式会社 リーク検査装置
GB9306106D0 (en) * 1993-03-24 1993-05-12 Norbrook Lab Ltd Sustained release veterinary composition
DE4440141A1 (de) * 1994-11-10 1996-05-15 Hoechst Ag Neue kristalline Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung
GB9907916D0 (en) * 1999-04-07 1999-06-02 Takeda Chemical Industries Ltd Long-acting antibacterial composition
WO2003063877A1 (en) * 2002-02-01 2003-08-07 Akzo Nobel N.V. Cefquinome composition for intra-mammary administration in cattle

Also Published As

Publication number Publication date
ES2265590T3 (es) 2007-02-16
AR041713A1 (es) 2005-05-26
AU2003279302B2 (en) 2008-10-16
NO334158B1 (no) 2013-12-23
NZ539478A (en) 2006-05-26
DE60305728T2 (de) 2006-10-12
CN1326526C (zh) 2007-07-18
CO5700769A2 (es) 2006-11-30
PL208585B1 (pl) 2011-05-31
JP2006510607A (ja) 2006-03-30
CA2501395C (en) 2011-05-24
PT1558263E (pt) 2006-10-31
NO20051654L (no) 2005-05-24
EP1558263B1 (en) 2006-05-31
WO2004037265A1 (en) 2004-05-06
ATE327759T1 (de) 2006-06-15
DE60305728D1 (de) 2006-07-06
CN1705483A (zh) 2005-12-07
ZA200502956B (en) 2006-03-29
PL376840A1 (pl) 2006-01-09
EP1558263A1 (en) 2005-08-03
MXPA05004219A (es) 2005-06-08
BRPI0315513B1 (pt) 2017-11-28
JP4584715B2 (ja) 2010-11-24
CA2501395A1 (en) 2004-05-06
AU2003279302A1 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
BR0315513A (pt) Composição farmacêutica injetável, processo para preparação de composição farmacêutica, e, uso de cefquinoma em um veìculo com liberação prolongada
BRPI0618918B8 (pt) uso de um primeiro composto e um segundo composto para tratar uma condição de glicose sanguínea
BRPI0506829A (pt) composições de anticonvulsivo e droga antipsicótica e métodos para sua utilização para afetar perda de peso
BR0111196A (pt) Composições e uso das mesmas para tratamento de flavivìrus e pestivìrus
UY26496A1 (es) Composiciones farmacéuticas que proporcionan concentraciones potenciadas de fármaco
BRPI0418029A (pt) formulação de anticorpos cd40 e métodos
BR0109150A (pt) Método para administração de um anestésico local a um indivìduo em necessidade de um efeito anestésico local, emplastro, composição, e, recipiente
AR047841A1 (es) Metodos y composiciones para el tratamiento de transtornos inmunoinflamatorios
ES2185606T3 (es) Nuevo uso de una clase de compuestos peptidicos para tratamiento de la alodinia u otros tipos diferentes de dolor cronico o fantasma.
PA8586201A1 (es) Nuevas formulaciones de liberacion prolongada inyectables
CO5690539A2 (es) Formulacion y metodo de aripiprazol inyectable esteril de liberacion controlada
ES2570856T3 (es) Composiciones oftálmicas que contienen una combinación sinérgica de dos polímeros
ECSP056071A (es) Nueva difenilazetidinona con características fisiológicas mejoradas, correspondiente método de producción, medicamentos que contienen dicho compuesto y su uso
EA200300929A1 (ru) Новые лекарственные композиции на основе антихолинергических средств и ингибиторов pde-iv
BRPI0406883A (pt) Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
BR0010716A (pt) Compostos de fenila substituìdos com atividade imunossupressora e composições farmacêuticas
BRPI0410555A (pt) preparação sólida
ATE513562T1 (de) Nicht-spezifische immunstimulierende mittel
WO2007056142A3 (en) Methods of preventing the serotonin syndrome and compositions for use therefor
BRPI0607084A2 (pt) uso de um composto 11-desóxiprostaglandina, composição compreendendo o mesmo, e composto
BRPI0412971A (pt) método de alongamento do cabelo
BRPI0212298B8 (pt) composição farmacêutica compreendendo gabapentina ou um análogo da mesma e (alfa)-aminoamida e seu uso analgésico
BRPI0407652A (pt) método para acentuar a eficácia de um agente ativo, composição e método para produzir a composição
BRPI0414979A (pt) preparação sólida
BR0312814A (pt) Levamisol / avermectinas ou similares em solvente de pirrolidona

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: INTERVET INTERNATIONAL B.V. (NL)

Free format text: TRANSFERIDO DE: AKZO NOBEL N.V.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM OS ARTIGOS 8O E 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]